Showing results (711-720 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|June 26, 2025
Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical TrialMin Yan, Huimin Lv, Xinlan Liu, et al.
JAMA Oncology|June 23, 2025
Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-AnalysisNida Saleem, Jiayue Wang, Angela Rejuso, et al.
JAMA Oncology|February 13, 2025
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical TrialMaria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, et al.
JAMA Oncology|December 19, 2024
Radiation Myelitis Risk After Hypofractionated Spine Stereotactic Body Radiation TherapyChristopher B Jackson, Lillian A Boe, Lei Zhang, et al.
JAMA Oncology|January 2, 2025
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical TrialStephen Daw, Peter D Cole, Bradford S Hoppe, et al.
JAMA Oncology|February 20, 2025
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A ReviewAnna DeVine, Wendy Landier, Melissa M Hudson, et al.
JAMA Oncology|January 9, 2025
Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology TherapiesKanika Arora, Sarah P Suehnholz, Hongxin Zhang, et al.
JAMA Oncology|March 20, 2025
Accelerated Aging in Survivors of Childhood Cancer-Early Onset and Excess Risk of Chronic ConditionsJennifer M Yeh, Zachary J Ward, Kayla L Stratton, et al.
JAMA Oncology|March 6, 2025
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy: The POLAR Randomized Clinical TrialLaura L Michel, Daniel Schwarz, Philipp Romar, et al.
JAMA Oncology|January 17, 2025
Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical TrialKirithiga Ramalingam, Rachel Woody, Alexa Glencer, et al.
Pageof 161